COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
T1D Strong: Father and Son Paul and Nick Peloso Discuss Growing Up with Type 1 Diabetes and the Breakthrough T1D Therapy Paul Is Developing
